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a b s t r a c t
One of the potential treatment methods of obesity is deep brain stimulation (DBS) of nucleus
accumbens. We describe the case of 19 years old woman with hypothalamic obesity. She
weighted 151.4 kg before DBS and the non-surgical methods proved to be inefﬁcient. She was
treated with implantation of DBS electrode to nucleus accumbens bilaterally. Results were
measured with body mass index and neuropsychological tests. Follow-up was 14 months.
Fourteen months after surgery weight was 138 kg, BMI was 48.3. Neuropsychological test
results were intact. The presented case supports the thesis of treatment of obesity with
nucleus accumbens stimulation.
# 2016 Polish Neurological Society. Published by Elsevier Sp. z o.o. All rights reserved.
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According to WHO, overweight and obesity are deﬁned as
abnormal or excessive fat accumulation that may impair
health. For the classiﬁcation and deﬁnition of overweight and
obesity BMI index is used and is deﬁned as a person's weight in
kilograms divided by the square of his height in meters (kg/m2).
BMI greater than or equal to 25 means overweight, BMI greater
than or equal to 30 is obesity. Worldwide obesity is a major
health problem constituting the ﬁfth leading risk for global
deaths [1].
Obesity is preventable by changes in dietary and physical
activity patterns. Modiﬁcation of diet and exercises has
important but limited impact on overcome of obesity and* Corresponding author at: Department of Neurosurgery, 10 Military H
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0028-3843/# 2016 Polish Neurological Society. Published by Elsevier Soverweight [2]. Pharmacologic therapy show rather modest
effects and is associated with side effects e.g. orlistat causing
gastrointestinal intolerance. Surgical options in management of
obesity aim decrease of volume of stomach: bands placed
around stomach, sleeve gastrectomy, gastroplasty and gastric
bypass surgery creating small stomach pouch. These proce-
dures cause vitamin and protein, microelements deﬁciencies
and have high risk of postoperative complications [3]. Several
experimental studies on animals showed beneﬁcial effect of
hypothalamic stimulation on reduction of hunger, inhibition of
food intake and weight loss [4,5]. Few studies on deep brain
stimulation of hypothalamus in humans demonstrated inﬂu-
ence on feeding behavior and weight reduction but showed also
some adverse effects and followed regain of the weight.
Therefore some authors propose another therapeutic approach,ospital, Powstańców Warszawy 5 Str, 86-681 Bydgoszcz, Poland.
p. z o.o. All rights reserved.
Picture 1 – Planned electrode trajectory on coronal MRI.
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accumbens (NAcc) [5–11].
2. Case
We describe the case of 19 years old woman with pathological
obesity. She suffered from hypothalamic obesity due to the
earlier craniopharyngioma surgery performed in 2004. She had
damaged hypothalamus by tumor and surgery. She weighted
151.4 kg before surgery and all of the current non-surgical
methods proved to be inefﬁcient. She suffered from glucose
intolerance, lumbar spondylosis, low self-assessment and
mild depression. The patient was gaining weight, craving for
food like an addict for drugs. She was under parental control all
the time, even the refrigerator was locked with a padlock. She
was qualiﬁed for bariatric surgery by her endocrinologist and
general surgeons. But the patient and her family had some
concerns about bariatric surgery. After approval of the local
bioethical committee she was treated with implantation of
DBS electrode to nucleus accumbens bilaterally. The follow-up
lasted fourteen months.
The target of stimulation was deﬁned bilaterally in nucleus
accumbens. The trajectory was planned through the ante-
rolateral part of the anterior limb of internal capsule (Picture 1).
Then in general anesthesia both electrodes were inserted
alongside the planned trajectories under the control of X-ray.
The correct placement of the electrodes was conﬁrmed by
intraoperative CT-MRI fusion. In the next stage of the operation
the stimulator was implanted in the right subcutaneousPicture 2 – Body Mass Index befosubclavian pocket. The procedure lasted about three hours.
On the day of surgery the stimulator was turned on. We used in
both electrodes bipolar stimulation with polarity () to contact
one electrode and (+) on the contact 4 electrodes, 208 ms pulse
width, frequency 130 Hz, 2 mA stimulation current. The patient
very well tolerated the stimulation, there were no side effects of
treatment. During her stay at the hospital and at monthly
outpatient visits the parameters of stimulation were modiﬁed
reaching at last the value of 3.75 mA, while keeping the other
parameters without alteration. Patient since surgery was under
neuropsychological and psychotherapeutic care. She had been
monitored on mental state, cognitive performance, and weight
control. The process of psychotherapy was to maintain
therapeutic effect of surgery. It was focused on patient lifestyle
changes, taking into account the context of her family. To assess
the severity of depressive symptoms we used Beck Depression
Inventory (BDI). The following neuropsychological tests of
cognitive performance testing were carried out: Wisconsin
Card Sorting Test (WCST), Trail Making Test (TMT), A and B and
Interference Test Names and Color Stroop (Stroop Color-Word
Interference Test). The neuropsychological examination and
measurement of body weight before surgery was performed
implantation in the 6th postoperative day, and 1, 3, 7 and 14
months after surgery.
3. Results
Three months after surgery weight was 132 kg, BMI was 46.2.
Neuropsychological test results were intact. Weight control
and neuropsychological test results before and after the
treatment further studies are presented in Picture 2. Prior to
surgery the patient weight was 151.4 kg and height 160 cm
(BMI – 52, 9). BDI results testify to the presence of mild
depressive syndrome, conﬁrming the information obtained
from the conversation with the patient. The results of
neuropsychological tests before surgery showed a signiﬁcantly
reduced psychomotor speed in a simple visual-spatial task
(TMT A) and the reduction of motor parameters, visual-spatial
working memory while retaining the ability to combine the
two principles of action of her memory (TMT B). Executive
functions (WCST), the speed of reading and verbal working
memory (Stroop) were normal. After surgery in the other three
examinations the progressive loss of body weight of the
patient was observed. Three months after the treatment she
weighted 19.6 kg less. The decline in body weight wasre surgery and in follow-up.
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Over the next four months the patient took on the weight
reaching in the 9th month 142 kg. In the next 4 months, the
patient lost 5 kg. During a latest visit her weight was 138 kg.
These ﬂuctuations may be related to the switching off by
accident of the pacemaker, which was noted twice. During the
switch off periods she reported increased craveing for food.
Currently, she shows no evidence of a depressive syndrome.
The patient reported feeling better, having more energy and
willingness to act. She has no feeling of increased appetite nor
increased need for food. She is satisﬁed with the results
brought by the treatment. Before the operation she had failed
to get the weight loss of more than 5 kg. It should be noted,
however, that during the growth of body weight (142 kg)
patient experienced a slight discomfort (6 points on the BDI),
but it was not signiﬁcant. In terms of cognitive neuropsychol-
ogy the test results indicate a gradual improvement in
psychomotor performance in visual-spatial working memory,
which in the third examination were normalized and
remained at that level until the last test. In the ﬁrst two tests
performed after surgery tests examining the efﬁciency of
executive functions decreased slightly (WCST), but they
remained consistently within normal limits. In the third
examination, the improvement of the results was close to the
level before treatment.
4. Discussion
Food intake and energy balance is under control of homeo-
static and non-homeostatic pathways [12–15]. Homeostatic
control pathways are based on hypothalamus with inputs
from digestive tract and vagal nerve. Sometimes non-
homeostatic systems overtake control over hypothalamus
[12]. They depend on reward system and cortico-limbic
structures [12,16,17]. We describe a patient with pathological
obesity after craniopharyngioma surgery. Such hypothalamic
obesity is common in patients after any lesions in the
hypothalamic region, affecting homeostatic mechanisms of
hunger and satiety [18–21]. Some authors state that bariatric
obesity is inefﬁcient in such cases [3]. There are several
approaches based on deep brain stimulation of different
targets in the treatment of pathological obesity, among them
hypothalamus and nucleus accumbens [6,7,11]. These
approaches are targeted on modulation of hypothalamic
homeostatic networks or on modulation of immediate reward
(‘‘limbic’’) circuits.
The data on weight and BMI indicate the presence of
morbid obesity, which signiﬁcantly limited the patient's daily
functioning. The patient also reported distimia, unwillingness
to act, understated self-esteem and lack of motivation to make
further efforts for weight loss, which was connected with
earlier failures in this regard. Attempts to make physical
activity and diet did not produce the desired effect. We have
chosen nucleus accumbens because a scar after craniophar-
yngioma surgery distorted anatomy of hypothalamic region,
thus making the targeting less reliable. Moreover, the
published data on neurophysiology, animal models and
human cases suggest the role of nucleus accumbens in
immediate reward circuits [11]. NAcc stimulation is provento be effective for example in drugs, nicotine and alcohol
dependence [7,8,22]. We have decided to treat the patient as
dependent from food intake. This approach may be also
supported with our own experience with surgical treatment of
obsessive-compulsive disease (OCD). The results of the
neuropsychological tests indicate the relative stability of
cognitive functioning of verbal memory and psychomotor
speed after the surgery. Our yet unpublished case of a patient
with OCD treated with bilateral nucleus accumbens stimula-
tion proves the role of this structure in compulsive behavior,
which may be also connected with craving for food. Modula-
tion of Nacc activity resulted in fast weight loss in the
presented case without psychological deterioration. This may
support the hypothesis of important role of limbic system in
pathogenesis of obesity after hypothalamic lesion.
5. Conclusion
The presented case supports the hypothesis that modulation
of immediate brain reward system may play a signiﬁcant role
in treatment of hypothalamic obesity.
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